Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasagiline for depressive symptoms and cognition in non-demented Parkinson's disease
2009-011144-19Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Nov 2009
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD), major depressive disorder (MDD) and confusion comparing Rasagiline with Placebo (2 arms). Primary endpoint: Change from baseline in BDI-IA total score. Started Nov 2009; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)major depressive disorder (MDD)confusion
Beyond the preview
Go deeper on 2009-011144-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011144-19.